|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/506 | |
| A61K 31/519 | |||
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3038652 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14766301.7 |
| Europos patento paraiškos padavimo data | 2014-08-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-07-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-03-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/053244 |
| Data | 2014-08-28 |
| (87) | Numeris | WO 2015/031666 |
| Data | 2015-03-05 |
| (30) | Numeris | Data | Šalis |
| 201361871275 P | 2013-08-28 | US |
| (72) |
HARRIS, Jennifer Leslie, US
LI, Nanxin, US
SMITH, Timothy R., US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES |
| COMBINATION OF AN ALK INHIBITOR AND A CDK INHIBITOR FOR THE TREATMENT OF CELL PROLIFERATIVE DISEASES |